Clinical trial
A Clinical Evaluation of the Safety, In-Use Tolerability, and Efficacy of the Utixira Lotion and Utixira Tablet Combination Regimen in Healthy Adults With Dry, Sensitive Skin Prone to Mild to Moderate Pruritus and Urticaria
NCT06924840 is registered in ClinicalTrials.gov with SAVA Healthcare Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Evaluation of the Safety, In-Use Tolerability, and Efficacy of the Utixira Lotion and Utixira Tablet Combination Regimen in Healthy Adults With Dry, Sensitive Skin Prone to Mild to Moderate Pruritus and Urticaria
- Lead sponsor
- SAVA Healthcare Limited
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- May 15, 2025
- Completion date
- June 15, 2025
- Enrollment
- 32 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.